Gu et al. reported an increase in circulating histone levels in patients with HCC following RFA treatment (Gu et al., 2015), Furthermore, after RFA treatment, myeloperoxidase (MPO) activity was significantly enhanced. This evidence concerns the gene MPO and hepatocellular carcinoma.